New Study Confirms Safety of Theranica's Sham Neuromodulation for Migraine with CGM Use Recent research validates that Theranica's Nerivio® REN wearable can be utilized safely alongside Continuous Glucose Monitoring systems, offering new hope for migraine patients with diabetes.

New Study Confirms Safety of Theranica's Sham Neuromodulation for Migraine with CGM Use #USA #Bridgewater #Migraine_Treatment #Nerivio #Theranica

Theranica Expands Nerivio Coverage Across U.S. to Nearly 130 Million Lives for Migraine Management Theranica's Nerivio wearable device is now covered by insurance for around 130 million Americans, revolutionizing migraine treatment options and access.

Theranica Expands Nerivio Coverage Across U.S. to Nearly 130 Million Lives for Migraine Management #United_States #Bridgewater #Migraine #Nerivio #Theranica

New Insurance Policy Expands Access to Drug-Free Migraine Care with Nerivio® REN Wearable A mid-Atlantic insurer has adopted a policy allowing over 3 million members access to the Nerivio® REN wearable for drug-free migraine management, enhancing treatment options.

New Insurance Policy Expands Access to Drug-Free Migraine Care with Nerivio® REN Wearable #USA #Bridgewater,_New_Jersey #Theranica #Migraine_Care #Nerivio_REN

Theranica's Nerivio® REN Wearable: A Breakthrough in Drug-Free Migraine Relief Discover how Theranica's Nerivio® REN wearable offers drug-free relief for migraine sufferers through innovative neuromodulation technology.

Theranica's Nerivio® REN Wearable: A Breakthrough in Drug-Free Migraine Relief #USA #Bridgewater #Migraine_Treatment #Nerivio #Theranica

Theranica's Nerivio® REN Wearable Achieves Landmark Study Results for Migraine Relief Theranica announces significant findings from a study involving 55,000 migraine patients, affirming the efficacy of its Nerivio® REN wearable.

Theranica's Nerivio® REN Wearable Achieves Landmark Study Results for Migraine Relief #USA #Bridgewater #Migraine_Relief #Nerivio #Theranica

Nerivio® REN Wearable for Migraine Treatment Approved in China Pier 88 Health and Theranica have announced the approval of their Nerivio® REN wearable device for the acute treatment of migraines in China, offering patients a non-drug solution.

Nerivio® REN Wearable for Migraine Treatment Approved in China #China #Beijing #Nerivio #Pier_88_Health #Theranica